• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Being overweight at any point in adulthood increases risk for death

byDeepti ShroffandCaitlyn Hui
April 4, 2017
in Cardiology, Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Maximum BMIs in overweight, obese, and obese II categories were associated with increases in risk for all-cause mortality.

2. This relationship between BMI and death was maintained regardless of smoking status, sex, and age.

Evidence Rating Level: 2 (Good)

Study Rundown: The relationship between optimal body mass index (BMI) and all-cause mortality lacks consensus. Some studies have identified an inverse association between those that are overweight and mortality, while others suggest that there is an increased risk of death in those that are overweight and obese. The controversial results of these studies are further compounded due to limitations observed in methodologies. To address these controversial results, the authors of this study aimed to investigate the relationship between maximum BMI over 16 years and subsequent mortality. In general, they observed that being overweight at any point in adulthood increases risk for death. This study is limited in its use of data, which was derived predominantly from white participants of high socioeconomic status. Additionally, there is the possibility of residual confounding by unmeasurable variables. Overall, the results of this study indicate that maximum BMI may be a more useful tool to assess all-cause mortality compared to single baseline BMI assessment. Additionally, the study further emphasizes the importance of healthy weight counseling and obesity-prevention measures to reduce all-cause mortality.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Body Mass Index and All-Cause Mortality in a Large Prospective Cohort of White and Black U.S. Adults

RELATED REPORTS

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

2 Minute Medicine Rewind December 15, 2025

GLP-1 receptor agonists show little effect on obesity-related cancer risk

In-Depth [retrospective cohort]: In total, 225 072 men and women were included in this study. Data was derived from 3 prospective cohort studies (the Nurses’ Health Study I, II, and the Health Professionals Follow-Up Study). All participants that had returned 2 questionnaires during the weight history periods for each cohort were included in the analysis, regardless of smoking status, baseline illness, and other characteristics. A general association between high BMI and all-cause mortality was observed. Specifically, maximum BMIs in the overweight (25.0 to 29.9 kg/m2) (multivariate hazard ratio [HR], 1.06 [95% CI, 1.03 to 1/08]), obese I (30.0 to 34.9 kg/m2) (HR, 1.24 [CI, 1.20 to 1.29]), and obese II (≥ 35.0 kg/m2) (HR, 1.73 [CI, 1.66 to 1.80]) categories were associated with increases in risk for all-cause death.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obesityoverweight
Previous Post

Body weight may not be the best way to assess cardiometabolic risk in some minority populations

Next Post

2 Minute Medicine Rewind April 3, 2017

RelatedReports

Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

December 19, 2025
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
Many new pediatric asthma cases attributable to obesity
Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

November 23, 2025
Next Post
Smoking during pregnancy associated with aerobic fitness of children

2 Minute Medicine Rewind April 3, 2017

Adding daratumumab increases progression free survival in multiple myeloma

Multiple myeloma management with lenalidomide, bortezomib and dexamethasone associated with prolonged progression-free survival

AAP addresses neonatal pain prevention

No link between antenatal betamethasone and abnormal childhood bone development

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
  • Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry
  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.